Related references
Note: Only part of the references are listed.Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold
Olaf Kinzel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
Yu Yao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
Derun Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy
Liping Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1
Emily C. Cherney et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology
Ryoichi Saito et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors
Xiaohan Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Guru Sonpavde et al.
FUTURE ONCOLOGY (2020)
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors
Yi-Hui Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Filippo Galli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity
Marta Serafini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
Gaia Giannone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective
Xi Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia
Hongbin Wan et al.
PLOS ONE (2020)
Subcutaneous inoculation position affects the immune environment in CT26 carcinomas
Xiaocong Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Target exposure and pharmacodynamics study of the indoleamine 2,3-dioxygenase-1 (IDO-1) inhibitor epacadostat in the CT26 mouse tumor model
Lauranne Poncelet et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
Ute F. Rohrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development
Mayanne M. T. Zhu et al.
CURRENT ONCOLOGY REPORTS (2019)
IDO1 in cancer: a Gemini of immune checkpoints
Lijie Zhai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form
Micah T. Nelp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Identification and characterization of the IDO1 inhibitor LY3381916
Frank C. Dorsey et al.
CANCER RESEARCH (2018)
Editorial: Targeting Metabolism in Cancer Immunotherapy
Jason Roszik et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mapping the Binding Trajectory of a Suicide Inhibitor in Human Indoleamine 2,3-Dioxygenase 1
Khoa N. Pham et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
Lieve Brochez et al.
EUROPEAN JOURNAL OF CANCER (2017)
Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indo1-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate
Stefano Crosignani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1
Ariel Lewis-Ballester et al.
NATURE COMMUNICATIONS (2017)
Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects
Abdulla A-B Badawy
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2017)
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
Yi-Hui Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation
Shawn P. Walsh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy
Christopher J. D. Austin et al.
DRUG DISCOVERY TODAY (2015)
Phase 1a study of the safety, pharmacokinetics, and pharmacodynamics of GDC-0919 in patients with recurrent/advanced solid tumors
A. Nayak et al.
EUROPEAN JOURNAL OF CANCER (2015)
Implementation of pharmacokinetic and pharrnacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research
Tove Tuntland et al.
FRONTIERS IN PHARMACOLOGY (2014)
Human Indoleamine 2,3-Dioxygenase Is a Catalyst of Physiological Heme Peroxidase Reactions IMPLICATIONS FOR THE INHIBITION OF DIOXYGENASE ACTIVITY BY HYDROGEN PEROXIDE
Mohammed Freewan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control
Andrew Teasdale et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2013)
Impact of Hydrolysis-Mediated Clearance on the Pharmacokinetics of Novel Anaplastic Lymphoma Kinase Inhibitors
Yohannes Teffera et al.
DRUG METABOLISM AND DISPOSITION (2013)
Enabling Lead Discovery for Histone Lysine Demethylases by High-Throughput RapidFire Mass Spectrometry
Sue E. Hutchinson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T Cells In Situ and Lymph Node Metastasis
Jinpu Yu et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Explanation for Main Features of Structure-Genotoxicity Relationships of Aromatic Amines by Theoretical Studies of Their Activation Pathways in CYP1A2
Igor Shamovsky et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
An in Silico Method for Predicting Ames Activities of Primary Aromatic Amines by Calculating the Stabilities of Nitrenium Ions
Joerg Bentzien et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Mild and General One-Pot Reduction and Cyclization of Aromatic and Heteroaromatic 2-Nitroamines to Bicyclic 2H-Imidazoles
Emily J. Hanan et al.
SYNLETT (2010)
Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model
Eddy W. Yue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis of bicyclo[3.1.0]hexane derivatives as conformationally restricted analogues of β-arabinofuranosyl and α-galactofuranosyl rings
Jing Li et al.
ORGANIC LETTERS (2008)
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
Ciriana Orabona et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons
Thomas R. Hoye et al.
NATURE PROTOCOLS (2007)
Medicinal chemistry of hERG optimizations: Highlights and hang-ups
Craig Jamieson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Understanding how the herpes thymidine kinase orchestrates optimal sugar and nucleobase conformations to accommodate its substrate at the active site: A chemical approach
VE Marquez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Synergistic transcriptional activation of indoleamine dioxygenase by IFN-γ and tumor necrosis factor-α
CM Robinson et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
N-tert-Butanesulfinyl imines:: Versatile intermediates for the asymmetric synthesis of amines
JA Ellman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2002)
Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-γ-activated human macrophages:: Posttranslational regulation by pyrrolidine dithiocarbamate
SR Thomas et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
